市場調查報告書
商品編碼
1551266
2030 年獸醫設備市場預測:按產品類型、動物類型、應用、最終用戶和地區分類的全球分析Veterinary Equipment Market Forecasts to 2030 - Global Analysis By Product Type, Animal Type, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球獸醫設備市場規模為 22 億美元,預計在預測期內將以 9.1% 的複合年成長率成長,到 2030 年達到 38 億美元。
獸醫設備是獸醫專業人員用於護理、治療和管理動物的專用儀器、工具和裝置。該設備專為獸醫學而設計,對於為動物提供優質醫療護理至關重要。獸醫設備還包括治療期間追蹤生命徵象的監測設備、用於復健的復健設備以及注射器、繃帶和導管等基本消耗品。這些設備專為動物設計,考慮到動物物種之間解剖學和生理學的差異。
據同一消息來源稱,到2023年,波蘭超過49%的家庭將擁有至少一隻狗,超過40%的家庭將擁有一隻貓。此外,動物健康組織 2022 年 9 月發布的《全球寵物照護狀況》報告強調,歐洲以及美國、巴西和中國的家庭擁有超過 5 億隻狗和貓。
世界各地飼養的寵物數量增加
寵物主人數量的不斷增加,對獸醫服務的需求急劇增加,需要提供常規檢查、疫苗接種和緊急治療的設備。因此,動物產品市場依然強勁。此外,將寵物視為家庭成員增加了人們對寵物健康和福祉的興趣,寵物飼主對優質獸醫護理的投資和採用最尖端科技正在推動市場成長。
獸醫設備高成本
獸醫設備成本的上漲減少了對先進設備的需求,特別是在小型診所。因此,更便宜的替代設備可能會成為首選,這可能會影響護理品質。此外,高昂的設備成本可能會阻礙飼主尋求必要的獸醫服務,導致例行檢查延遲和動物健康惡化。因此,獸醫醫療設備的需求可能會進一步下降。
提高對通用感染疾病的認知
人們對通用感染疾病的認知不斷提高,導致對先進獸醫診斷設備(例如成像技術和分子診斷)的需求激增,以快速準確地檢測病原體。這用於防止這些疾病傳播給人類。此外,人們的意識不斷提高,人們開始關注疫苗接種、生物安全和感染控制通訊協定等預防措施,以確保疫苗的安全處理和管理。
缺乏動物保健意識
寵物飼主往往對定期獸醫醫療照護的重要性認知不足,導致去獸醫診所就診的次數減少,對獸醫設備的需求也減少。在動物保健意識較低的地區,對先進技術的投資也受到限制,因為獸醫可能會選擇基本工具而不是先進的診斷或手術設備。這抑制了創新並限制了高品質動物用藥品的市場。
COVID-19 大流行擾亂了供應鏈,導致生產延誤和基本產品短缺,對獸醫設備市場產生了重大影響。由於封鎖,例行檢查和選擇性手術等非必要的獸醫服務被推遲,從而減少了對手術器械和麻醉用品等相關設備的需求。此外,由於安全通訊協定和個人防護設備的需求而增加的營運成本進一步使獸醫院不堪重負。
診斷設備產業預計將在預測期內成為最大的產業。
由於先進的診斷設備改善了疾病的早期發現並帶來更好的治療結果,預計診斷設備將在預測期內達到頂峰。這增加了寵物飼主對獸醫護理的需求。就地檢驗、遠端醫療和人工智慧主導的診斷等技術進步正在改變獸醫實踐,提高診斷準確性,簡化業務,並使服務更加高效和便捷。
預計監控產業在預測期內複合年成長率最高
為了確保寵物的健康,寵物飼主對預防性醫療保健的興趣日益濃厚,導致監控設備的使用增加。隨著寵物飼主尋求全面的醫療保健解決方案,這轉化為積極的經濟影響,推動獸醫設備市場的成長。
尤其是美國和加拿大的寵物擁有率很高,推動了對獸醫服務和設備的需求。該地區擁有配備最尖端科技的先進診所和醫院,透過高品質的診斷、手術和監測設備確保提供頂級的獸醫護理。
由於人們對動物健康和福利的認知不斷提高,推動了對獸醫護理的投資並推動了對高品質設備的需求,預計亞太地區在預測期內將保持最高的複合年成長率。此外,亞太地區日益嚴格的法規要求使用可靠、有效的獸醫設備,有助於符合動物健康和福利法規的市場成長。
According to Stratistics MRC, the Global Veterinary Equipment Market is accounted for $2.2 billion in 2024 and is expected to reach $3.8 billion by 2030 growing at a CAGR of 9.1% during the forecast period. Veterinary equipments are the specialized instruments, tools, and devices used by veterinary professionals for the care, treatment, and management of animals. This equipment is designed specifically for use in veterinary medicine and is essential for providing high-quality medical care to animals. Veterinary equipment also encompasses monitoring devices that track vital signs during treatment, rehabilitation tools for recovery, and basic supplies such as syringes, bandages, and catheters. This equipment is designed to be animal-specific, considering the differences in anatomy and physiology between species.
According to the same source, in Poland, over 49% of the households owned at least one dog, and over 40% owned a cat in 2023. In addition, the Global State of Pet Care report published by the HealthForAnimals Organization in September 2022 highlighted that over half a billion dogs and cats were adopted by families in Europe, along with the United States, Brazil, and China.
Rising number of pet ownership globally
The growing number of pet owners has led to a surge in demand for veterinary services, necessitating a greater supply of equipment for routine check-ups, vaccinations, and emergency care. This has led to a robust market for veterinary supplies. The perception of pets as family members has also increased the focus on their health and well-being, encouraging pet owners to invest in high-quality veterinary care and adopting cutting-edge technologies boosting the market growth.
High cost of veterinary equipment
The rising costs of veterinary equipment are leading to a decrease in demand for advanced equipment, particularly in smaller clinics. This may result in a preference for less expensive alternatives, potentially affecting the quality of care. Additionally, high equipment costs can discourage pet owners from seeking necessary veterinary services, leading to postponement of routine check-ups and deterioration of animal health. This could further reduce the demand for veterinary equipment.
Growing awareness of zoonotic diseases
Growing awareness of zoonotic diseases has led to a surge in demand for advanced veterinary diagnostic equipment, such as imaging technologies and molecular diagnostics, to detect pathogens quickly and accurately. This is being used to prevent the spread of these diseases to humans. Additionally, the increased awareness has prompted a focus on preventive measures, such as vaccination, biosecurity, and infection control protocols, to ensure safe handling and administration of vaccines.
Lack of animal healthcare awareness
Pet owners often lack awareness of the importance of regular veterinary care, leading to fewer visits and reduced demand for veterinary equipment. This also results in limited investment in advanced technologies, as veterinarians may opt for basic tools over advanced diagnostic or surgical equipment in regions with low awareness of animal healthcare. This stifles innovation and limits the market for high-quality veterinary products.
The COVID-19 pandemic significantly impacted the veterinary equipment market by disrupting supply chains, leading to manufacturing delays and shortages of essential products. Lockdowns resulted in the postponement of non-essential veterinary services, such as routine check-ups and elective procedures, which decreased demand for related equipment like surgical instruments and anesthesia supplies. Additionally, increased operational costs due to safety protocols and the need for personal protective equipment further strained veterinary practices.
The diagnostic equipment segment is expected to be the largest during the forecast period
The diagnostic equipment is expected to be the largest during the forecast period because advanced diagnostic equipment improves early disease detection, leading to better treatment outcomes. This increases pet owners' demand for veterinary care. Technological advancements like point-of-care testing, telemedicine, and AI-driven diagnostics are transforming veterinary practices, improving diagnostic accuracy and streamlining operations, making services more efficient and accessible.
The monitoring segment is expected to have the highest CAGR during the forecast period
The monitoring segment is expected to have the highest CAGR during the forecast period owing to the growing focus on preventive care among pet owners has led to an increase in the use of monitoring equipment, driven by the desire to ensure their animals' health. This has led to a positive economic impact, as pet owners seek comprehensive health management solutions, driving market growth in the veterinary equipment market.
North America is projected to hold the largest market share during the forecast period particularly the US and Canada, has high pet ownership rates, driving demand for veterinary services and equipment. The region boasts advanced clinics and hospitals equipped with cutting-edge technology, ensuring top-tier veterinary care with high-quality diagnostic, surgical, and monitoring equipment.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the growing awareness of animal health and welfare is driving investment in veterinary care, boosting demand for high-quality equipment. Additionally, stricter regulations in the Asia-Pacific region necessitate the use of reliable and effective veterinary equipment, contributing to market growth in compliance with animal health and welfare regulations.
Key players in the market
Some of the key players in Veterinary Equipment market include Avante Animal Health, B. Braun Vet Care GmbH, Becton, Dickinson and Company, Covetrus, Digicare Biomedical Technology Inc., Dispomed Ltd, Jorgensen Labs., Masimo, Medtronic PLC, Midmark Corporation, Mindray Medical International Limited, Nonin, Smiths Medical Inc. and Vetland Medical Sales & Services, LLC
In July 2024, BD and Quest Diagnostics announced a global collaboration agreement to develop, manufacture and commercialize flow cytometry-based companion diagnostics (CDx), intended to help select the best treatment for patients with cancer and other diseases.
In June 2024, BD and Edwards Lifesciences announced a definitive agreement under which BD will acquire Edwards' Critical Care product group, for $4.2 billion in cash, unlocking new value creation opportunities and enhancing BD's portfolio of smart connected care solutions.
In August 2024, Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval for its Simplera(TM) continuous glucose monitor (CGM), all-in-one CGM that's half the size of previous Medtronic CGMs. The discreet design simplifies the insertion and wear experience, eliminating the need for overtape.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.